Cargando…
Oxycodone Controlled Release in Cancer Pain Management
Oral opioids are the treatment of choice for chronic cancer pain. Morphine is the strong opioid of choice for the treatment of moderate to severe cancer pain according to guidelines from the World Health Organization (WHO). This recommendation by the WHO was derived from availability, familiarity to...
Autor principal: | Biancofiore, Giuseppe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936259/ https://www.ncbi.nlm.nih.gov/pubmed/18360598 |
Ejemplares similares
-
Profile of extended-release oxycodone/acetaminophen for acute pain
por: Bekhit, Mary Hanna
Publicado: (2015) -
Developments in managing severe chronic pain: role of oxycodone–naloxone extended release
por: Fanelli, Guido, et al.
Publicado: (2015) -
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial
por: Lee, Kyung-Hee, et al.
Publicado: (2017) -
The place of oxycodone/naloxone in chronic pain management
por: Leppert, Wojciech
Publicado: (2013) -
Use of Oxycodone in Pain Management
por: Moradi, Mohammad, et al.
Publicado: (2012)